Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.
about
Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells.Durable response after just one cycle of belotecan-based chemotherapy in a patient with relapsed primary peritoneal serous carcinoma.Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
P2860
Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase II study of belotecan, a ...... t of recurrent ovarian cancer.
@ast
Phase II study of belotecan, a ...... t of recurrent ovarian cancer.
@en
type
label
Phase II study of belotecan, a ...... t of recurrent ovarian cancer.
@ast
Phase II study of belotecan, a ...... t of recurrent ovarian cancer.
@en
prefLabel
Phase II study of belotecan, a ...... t of recurrent ovarian cancer.
@ast
Phase II study of belotecan, a ...... t of recurrent ovarian cancer.
@en
P2093
P2860
P356
P1433
P1476
Phase II study of belotecan, a ...... t of recurrent ovarian cancer.
@en
P2093
Byoung-Gie Kim
Chel Hun Choi
Duk-Soo Bae
Hwang-Shin Park
Jeong-Won Lee
Min Kyu Kim
Tae-Jong Song
Tae-Joong Kim
Yoo-Young Lee
P2860
P304
P356
10.1002/CNCR.25710
P407
P577
2010-11-29T00:00:00Z